Pediatric Precision Medicine Cancer Care Summit

The University of California, San Francisco, School of Medicine, and the Children’s Hospital of Philadelphia are pleased to present the 2nd Biennial Pediatric Precision Medicine Cancer Care Summit: Personalizing Pediatric Cancer Care: Innovation through Collaboration.

Location: Grand Hyatt San Francisco, San Francisco

Dates: March 22-23, 2024

The summit brings together leading experts to discuss the latest breakthroughs in precision medicine and how these advances are changing the landscape of pediatric cancer care, research and precision-based oncology.

CME credits will be available.

Objectives

• Articulate the significance of recent advances in liquid biopsies, demonstrating their application in measuring minimal residual disease and early detection of relapse.
• Investigate and appraise new therapeutic opportunities for patients in the relapsed setting using next-generation sequencing panels, while critically assessing the limitations of this technology.
• Analyze and differentiate the frequency and diversity of germline alterations relevant to cancer diagnosis in children and young adults.
• Apply knowledge of germline alterations to implement precise screening practices for patients with cancer and their families.
• Evaluate and address current barriers impeding the widespread use of immunotherapy in pediatric cancer.
• Recognize and assess the emerging importance of CART and other cell therapies in pediatric cancer.

Course Outline and Registration available here.